| Robert Michael Cargile, MD | |
|
10166 Big Canoe, Big Canoe, GA 30143-5118 | |
| (706) 579-1614 | |
| (706) 579-1617 |
| Full Name | Robert Michael Cargile |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 10166 Big Canoe, Big Canoe, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346227410 | NPI | - | NPPES |
| 00532287C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 034310 (Georgia) | Primary |
| Entity Name | Compass Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295028082 PECOS PAC ID: 8820269871 Enrollment ID: O20110922000432 |
News Archive
The settlement comes in what has been a closely watched Medicare overbilling case filed against Halifax Hospital.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries announced today its patented pTeroPure (pterostilbene) was shown to be safe for human consumption according to data from the first clinical trial of the substance.
The COVID-19 pandemic has escalated into a ‘syndemic' for people with chronic illnesses, a new UNSW study analysing data from low and middle-income countries shows.
› Verified 8 days ago
| Entity Name | Compass Providence Urgent Care Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770997579 PECOS PAC ID: 3375865934 Enrollment ID: O20141210000235 |
News Archive
The settlement comes in what has been a closely watched Medicare overbilling case filed against Halifax Hospital.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries announced today its patented pTeroPure (pterostilbene) was shown to be safe for human consumption according to data from the first clinical trial of the substance.
The COVID-19 pandemic has escalated into a ‘syndemic' for people with chronic illnesses, a new UNSW study analysing data from low and middle-income countries shows.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Michael Cargile, MD 10166 Big Canoe, Big Canoe, GA 30143-5118 Ph: (706) 579-1614 | Robert Michael Cargile, MD 10166 Big Canoe, Big Canoe, GA 30143-5118 Ph: (706) 579-1614 |
News Archive
The settlement comes in what has been a closely watched Medicare overbilling case filed against Halifax Hospital.
The measure, dubbed the Patient Choice, Affordability, Responsibility and Empowerment Act, is being advanced by Sens. Richard Burr of North Carolina, Orrin Hatch of Utah and Tom Coburn of Oklahoma. It may provide a window into how Republicans plan to handle health reform issues in the upcoming election cycle and beyond.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries announced today its patented pTeroPure (pterostilbene) was shown to be safe for human consumption according to data from the first clinical trial of the substance.
The COVID-19 pandemic has escalated into a ‘syndemic' for people with chronic illnesses, a new UNSW study analysing data from low and middle-income countries shows.
› Verified 8 days ago